Eucodis Bioscience (Vienna) a commercial-stage company focused on the development, customization, manufacture and marketing of industrial enzymes, closed a $2.7m Series B financing. Participants include Pontis Capital, Wiener Wachstumsfonds and Arax Capital Partners.